Preliminary results from a phase II study of lenalidomide monotherapy in Relapsed/Refractory aggressive non-Hodgkin's lymphoma.

被引：0
|
作者：
Wiemik, Peter H.
Lossos, Izidore
Tuscano, Joseph
Justice, Glen
Vose, Julie M.
Pietronigro, Dennis
Takeshita, Kenichi
Ervin-Haynes, Annette
Zeldis, Jerome B.
Habermann, Thomas M.
机构：
[1] Coll Med, Our Lady Canc Ctr, Bronx, NY 33152 USA
[2] Univ Miami, Sylvester Canc Ctr, Miami, FL 95817 USA
[3] Univ Calif Davis, Ctr Canc, Sacramento, CA USA
[4] Oncol Med Grp, Fountain Valley, CA 68182 USA
[5] Univ Nebraska, Omaha, NE USA
[6] Celgene Corp, Summit, NJ USA
[7] Mayo Clin, Rochester, MN USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
531
引用
收藏
页码：160A / 161A
页数：2
相关论文
共 50 条
  • [41] Gemcitabine as single agent in the treatment of relapsed and refractory Hodgkin's and non-Hodgkin lymphoma.
    Jajeh, A
    Hadad, L
    Zalzaleh, G
    Ruestow, P
    BLOOD, 2003, 102 (11) : 285B - 285B
  • [42] A Phase II Multicenter Study of Lenalidomide in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL): Preliminary Results.
    Fehniger, Todd A.
    Larson, Sarah
    Trinkaus, Kathryn
    Siegel, Marilyn J.
    DiPersio, John F.
    Cashen, Amanda F.
    Hurd, David D.
    Blum, Kristie A.
    Bartlett, Nancy L.
    BLOOD, 2008, 112 (11) : 899 - 900
  • [43] Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma
    Christian, Beth A.
    Huang, Ying
    Ayyappan, Sabarish
    Baiocchi, Robert A.
    Brammer, Jonathan E.
    Epperla, Narendranath
    Jaglowski, Samantha
    William, Basem M.
    Awan, Farrukh T.
    Maddocks, Kami J.
    Blum, Kristie A.
    BLOOD, 2019, 134
  • [44] Activity of oxaliplatin in patients with relapsed and refractory non-Hodgkin lymphoma.
    Younes, A
    McLaughlin, P
    Pro, B
    Hagemeister, FB
    Fayad, L
    Romaguera, J
    BLOOD, 2002, 100 (11) : 296B - 296B
  • [45] Phase II study of fludarabine and cyclophosphamide in the treatment of relapsed low grade non-Hodgkin's lymphoma.
    Lucie, NP
    Dunlop, DJ
    Soukop, M
    McKay, PJ
    Stark, AN
    Anderson, SM
    Paul, J
    BLOOD, 2001, 98 (11) : 606A - 607A
  • [46] Updated Results of a Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
    Christian, Beth A.
    Kuruvilla, John G.
    Smith, Sonali M.
    Porcu, Pierluigi
    Maddocks, Kami J.
    Ruppert, Amy S.
    Byrd, John C.
    Grever, Michael R.
    Blum, Kristie A.
    BLOOD, 2015, 126 (23)
  • [47] Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma
    Ribrag, Vincent
    Caballero, Dolores
    Ferme, Christophe
    Zucca, Emanuele
    Arranz, Reyes
    Briones, Javier
    Gisselbrecht, Christian
    Salles, Gilles
    Gianni, Alessandro M.
    Gomez, Henry
    Kahatt, Carmen
    Corrado, Claudia
    Szyldergemajn, Sergio
    Extremera, Sonia
    de Miguel, Bernardo
    Cullell-Young, Martin
    Cavalli, Franco
    HAEMATOLOGICA, 2013, 98 (03) : 357 - 363
  • [48] Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma
    Phillips, Tycel
    Chan, Henry
    Tam, Constantine S.
    Tedeschi, Alessandra
    Johnston, Patrick
    Oh, Sung Yong
    Opat, Stephen
    Eom, Hyeon-Seok
    Allewelt, Heather
    Stern, Jennifer C.
    Tan, Ziwen
    Novotny, William
    Huang, Jane
    Trotman, Judith
    BLOOD ADVANCES, 2022, 6 (11) : 3472 - 3479
  • [49] Phase II study of delineukin diftitox (ONTAK®) for relapsed/refractory band T-cell non-Hodgkin's lymphoma.
    Dang, NH
    Hagemeister, FB
    Fayad, L
    Pro, B
    McLaughlin, P
    Romaguera, JE
    Samaniego, F
    Younes, A
    Goy, A
    Preti, A
    Jones, D
    Sarris, A
    East, K
    Rodriguez, MA
    Cabanillas, F
    BLOOD, 2002, 100 (11) : 363A - 363A
  • [50] Cologne high-dose sequential chemotherapy in relapsed and refractory aggressive non-Hodgkin lymphoma - results of a multicentre Phase II study
    Josting, A
    Sieniawski, M
    Staak, JO
    Glossmann, JP
    Diehl, V
    Engert, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S245 - S245
12345